Biotest AG (ETR:BIO) | Finanzwire

Basculer en Français

11025	Companies
241656	Keywords
170132	Articles
130105	Press releases

Home
Companies
Biotest AG

PRESS RELEASE

published on 02/28/2024 at 10:00, 2 years 6 months ago

Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care
Prof Dr Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne, emphasizing vital contribution to patient care. Plasma donation in Germany crucial for medical supply

Germany Patient Care Biotest AG Karl Lauterbach Plasma Donation
BRIEF

published on 02/28/2024 at 10:00, 2 years 6 months ago

Visit of Karl Lauterbach to the plasma donation center of Biotest AG in Cologne

Germany Biotest AG Karl Lauterbach Plasma Donation Medical Care
PRESS RELEASE

published on 02/14/2024 at 08:30, 2 years 7 months ago

Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential

Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE

published on 11/28/2023 at 09:00, 2 years 9 months ago

EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE

published on 11/02/2023 at 08:00, 2 years 10 months ago

Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE

published on 10/05/2023 at 16:55, 2 years 11 months ago

EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE

published on 10/05/2023 at 16:42, 2 years 11 months ago

EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
PRESS RELEASE

published on 09/21/2023 at 09:00, 2 years 11 months ago

Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
PRESS RELEASE

published on 09/12/2023 at 09:00, 3 years ago

Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
PRESS RELEASE

published on 09/07/2023 at 09:00, 3 years ago

Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo

Accesswire

Published on 09/19/2026 at 00:55, 2 hours 38 minutes ago

Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 23:50, 3 hours 43 minutes ago

Mako Mining Announces Equity Incentive Grants
Published on 09/18/2026 at 22:00, 5 hours 33 minutes ago

Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 6 hours 58 minutes ago

Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 13 hours 3 minutes ago

AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement

View all ACCESSWIRE

EQS Group

Published on 09/18/2026 at 18:45, 8 hours 48 minutes ago

Holding(s) in Company
Published on 09/18/2026 at 18:44, 8 hours 49 minutes ago

EQS-Adhoc: Enapter AG announces preliminary, unaudited figures for the first half of 2026 and restructures its US sales operations – one-off expense of EUR 17 million
Published on 09/18/2026 at 18:13, 9 hours 20 minutes ago

Multi Units Luxembourg: NOTICE TO SHAREHOLDERS
Published on 09/18/2026 at 18:09, 9 hours 23 minutes ago

Multi Units Luxembourg: NOTICE TO SHAREHOLDERS
Published on 09/18/2026 at 18:07, 9 hours 26 minutes ago

Multi Units Luxembourg: NOTICE TO SHAREHOLDERS

Les Echos

Published on 09/18/2026 at 18:34, 8 hours 59 minutes ago

Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 17:45, 9 hours 48 minutes ago

Press Release_Carrefour Bond_September 2026
Published on 09/18/2026 at 17:45, 9 hours 48 minutes ago

Share buyback for cancellation
Published on 09/17/2026 at 17:40, 1 day 9 hours ago

Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 20:46, 2 days 6 hours ago

LNA SANTE : 2026 First Half Results

View all LES ECHOS COMFI WIRE